Boston Scientific profit up on heart device sales

Oct 22 (Reuters) - Boston Scientific Corp on Wednesday posted a third-quarter profit in line with analysts' expectations on stronger sales of its key implantable heart devices.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.